Not exact matches
Apoquel is a JAK - 1 inhibitor that is especially formulated and duly
approved by the FDA for use in the control and management of intense itching in dogs.
APOQUEL is the only animal health product
approved for both the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs over 12 months of age.
It is important to recognize the fact that the FDA does not
approve giving
Apoquel beyond these recommended limits.
APOQUEL was
approved by the U.S. Food and Drug Administration in May 2013 and is the first and only Janus kinase (JAK) inhibitor
approved for veterinary use.
The first drug in its class to be
approved for veterinary use,
Apoquel is specifically designed to address the source of the itch, providing fast - acting relief and minimal side effects.
APOQUEL is the only animal health product
approved for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs over 12 months of age.
Developed by Zoetis,
APOQUEL is the first Janus kinase (JAK) inhibitor
approved for veterinary use that targets the itch and inflammation pathway.
So might canine
Apoquel (although
Apoquel it is not FDA
approved for cats, some vets have experimentally used it.